Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryuzo Ueda

Showing results (271-280 of 333) with videos related to

Pageof 34
Sort By:
The Journal of General Virology|March 25, 2004
Epidemiological and sequence differences between two subtypes (Ae and Aa) of hepatitis B virus genotype AFuminaka Sugauchi, Hiromitsu Kumada, Subrat A Acharya, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|May 12, 2004
A randomized controlled trial of consensus interferon with or without lactoferrin for chronic hepatitis C patients with genotype 1b and high viral loadNoboru Hirashima, Etsuro Orito, Kenichi Ohba, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 18, 2011
ABO genotype and the risk of gastric cancer, atrophic gastritis, and Helicobacter pylori infectionMakoto Nakao, Keitaro Matsuo, Hidemi Ito, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 24, 2013
HTLV-1 bZIP factor-specific CD4 T cell responses in adult T cell leukemia/lymphoma patients after allogeneic hematopoietic stem cell transplantationTomoko Narita, Takashi Ishida, Ayako Masaki, et al.
Intervirology|August 24, 2006
Variations in the viral NS5B region in Japanese patients with chronic hepatitis C virus genotype 1b infection. No specific amino acid substitution was identified as determinants of treatment response to interferon/ribavirin combination therapyKanji Sugihara, Etsuro Orito, Yasuhito Tanaka, et al.
Journal for Immunotherapy of Cancer|April 3, 2025
Phase I study on neoadjuvant combination immunotherapy with mogamulizumab and nivolumab for solid tumorsKoichi Jinushi, Takuro Saito, Koji Kurose, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 5, 2013
Autologous Tax-specific CTL therapy in a primary adult T cell leukemia/lymphoma cell-bearing NOD/Shi-scid, IL-2Rγnull mouse modelAyako Masaki, Takashi Ishida, Susumu Suzuki, et al.
Blood|October 6, 2017
Enhancer profiling identifies critical cancer genes and characterizes cell identity in adult T-cell leukemiaRegina Wan Ju Wong, Phuong Cao Thi Ngoc, Wei Zhong Leong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2015
Phase Ia Study of FoxP3+ CD4 Treg Depletion by Infusion of a Humanized Anti-CCR4 Antibody, KW-0761, in Cancer PatientsKoji Kurose, Yoshihiro Ohue, Hisashi Wada, et al.
Hematological Oncology|September 17, 2020
Clinical significance of tryptophan catabolism in follicular lymphomaAyako Masaki, Takashi Ishida, Yasuhiro Maeda, et al.
Pageof 34

Showing results (271-280 of 333) with videos related to

Sort By:
Pageof 34
The Journal of General Virology|March 25, 2004
Epidemiological and sequence differences between two subtypes (Ae and Aa) of hepatitis B virus genotype AFuminaka Sugauchi, Hiromitsu Kumada, Subrat A Acharya, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|May 12, 2004
A randomized controlled trial of consensus interferon with or without lactoferrin for chronic hepatitis C patients with genotype 1b and high viral loadNoboru Hirashima, Etsuro Orito, Kenichi Ohba, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 18, 2011
ABO genotype and the risk of gastric cancer, atrophic gastritis, and Helicobacter pylori infectionMakoto Nakao, Keitaro Matsuo, Hidemi Ito, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 24, 2013
HTLV-1 bZIP factor-specific CD4 T cell responses in adult T cell leukemia/lymphoma patients after allogeneic hematopoietic stem cell transplantationTomoko Narita, Takashi Ishida, Ayako Masaki, et al.
Intervirology|August 24, 2006
Variations in the viral NS5B region in Japanese patients with chronic hepatitis C virus genotype 1b infection. No specific amino acid substitution was identified as determinants of treatment response to interferon/ribavirin combination therapyKanji Sugihara, Etsuro Orito, Yasuhito Tanaka, et al.
Journal for Immunotherapy of Cancer|April 3, 2025
Phase I study on neoadjuvant combination immunotherapy with mogamulizumab and nivolumab for solid tumorsKoichi Jinushi, Takuro Saito, Koji Kurose, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 5, 2013
Autologous Tax-specific CTL therapy in a primary adult T cell leukemia/lymphoma cell-bearing NOD/Shi-scid, IL-2Rγnull mouse modelAyako Masaki, Takashi Ishida, Susumu Suzuki, et al.
Blood|October 6, 2017
Enhancer profiling identifies critical cancer genes and characterizes cell identity in adult T-cell leukemiaRegina Wan Ju Wong, Phuong Cao Thi Ngoc, Wei Zhong Leong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2015
Phase Ia Study of FoxP3+ CD4 Treg Depletion by Infusion of a Humanized Anti-CCR4 Antibody, KW-0761, in Cancer PatientsKoji Kurose, Yoshihiro Ohue, Hisashi Wada, et al.
Hematological Oncology|September 17, 2020
Clinical significance of tryptophan catabolism in follicular lymphomaAyako Masaki, Takashi Ishida, Yasuhiro Maeda, et al.
Pageof 34